Atlas Trials

A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Clinical trial NCT02221869 · COMPLETED

Trial details

NCT number
NCT02221869
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Narcolepsy With Cataplexy
Start date
2014-10-01
Primary completion
2017-02-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.